Professor Sabe Sabesan, is the Clinical Dean of the Townsville Regional Medical Training network incorporating the Townsville Hospital and Health Services and the Townsville Clinical School of the James Cook University and the director of the department of Medical oncology at the Townsville Cancer Centre, Townsville Hospital.
The Professor recently wrote, “Workforce wellness and engagement have become buzzwords in healthcare settings since there is an intimate relationship between staff wellbeing and performance of the healthcare system. Wellness initiatives such as wellness champions and wellness committees have been set up in response to emerging workforce mental health issues. These are largely reactive rather than being proactive in addressing or preventing the root cause of mental health issues.”
“Within healthcare teams, the promotion of a strong sense of shared purpose along with strong leadership has been shown to reduce rates of mental health problems in staff. Many authorities believe that organisational values are the foundation of organisational culture, and alignment of values and purpose across all levels of organisations may minimise moral injury and promote positive emotions amongst staff.”, writes Professor Sabe Sabesan, in his article “Values aligned organisational culture as the foundation for workforce wellness Is it a pipe dream?” published in the Australian Healthcare and Hospitals Association’s, The Health Advocate magazine in August 2021.
Australian Health Journal interviewed the Professor on his article.
-
Pathology technology at a crossroads
The CEO of Pathology Technology Australia, Dean Whiting spoke with Australian Health Journal about the following:
– Pathology Technology Australia’s key priorities in the coming years
– Current local capability in pathology technology compared to other countries
– How the health system supports change and adoption of pathology technology
– How pathology is perceived by the public and in government as well as how developments in pathology technology are followed and understood
– Observations in the Strengthening Medicare Taskforce ReportIn the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
-
Strategic research investments for health and prosperity
The CEO of Research Australia, Nadia Levin spoke with Australian Health Journal about the following:
– Current medical research and development landscape in Australia
– Investment required to support the Health and Medical Research and Innovation pipeline
– The National Medical Products Industry Plan and its impact on the Australian economy
– The Health and Medical Research WorkforceIn the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
-
New option for management of high-risk soft tissue sarcoma of the limb
SARC032 is the first completed randomised clinical trial of its kind and has demonstrated compelling evidence to integrate immunotherapy, with the standard treatment regimen of radiotherapy and surgery for patients with grade 2 or 3, stage III soft tissue sarcoma of the limb.
